Matching plus regression adjustment for the estimation of the average treatment effect on survival outcomes: a case study with mosunetuzumab in relapsed/refractory follicular lymphoma
Abstract Background and objectives The National Institute for Health and Care Excellence (England’s health technology assessment body) recommend the use of the average treatment effect (ATE) as an estimand for economic evaluations. However there is limited literature on methods to estimate the ATE,...
Saved in:
Main Authors: | Danilo Di Maio, S. A. Mitchell, S. Batson, E. Keeney, Howard H. Z. Thom |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | BMC Medical Research Methodology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12874-025-02456-x |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Digital technologies and performance incentives: evidence from businesses in the Swiss economy
by: Johannes Lehmann, et al.
Published: (2025-01-01) -
Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
by: Tiago Torres, et al.
Published: (2024-04-01) -
A note on the probability structure of a doubly randomized delayed start design
by: Zhao Yang
Published: (2025-01-01) -
Enhancing Classification Models With Sophisticated Counterfactual Images
by: Xiang Li, et al.
Published: (2025-01-01) -
Heart failure subphenotypes based on mean arterial pressure trajectory identify patients at increased risk of acute kidney injury
by: Xiya Wang, et al.
Published: (2025-12-01)